Hsi-Yang Wu

Publication Details

  • Acute renal failure from xanthine nephropathy during management of acute leukemia PEDIATRIC NEPHROLOGY LaRosa, C., McMullen, L., Bakdash, S., Ellis, D., Krishnamurti, L., Wu, H., Moritz, M. L. 2007; 22 (1): 132-135


    Tumor lysis syndrome is a potentially life-threatening complication of induction chemotherapy for treatment of lymphoproliferative malignancies. Serious complications of tumor lysis syndrome are rare with the preemptive use of allopurinol, rasburicase, and urine alkalinization. We report a case of oliguric acute renal failure due to bilateral xanthine nephropathy in an 11-year-old girl as a complication of tumor lysis syndrome during the treatment of T-cell acute lymphoblastic leukemia. Xanthine nephrolithiasis results from the inhibition of uric acid synthesis via allopurinol which increases plasma and urinary xanthine and hypoxanthine levels. Reports of xanthine nephrolithiasis as a cause of tumor lysis syndrome are rare in the absence of defects in the hypoxanthine-guanine phosphoribosyl transferase (HGPRT) enzyme. Xanthine nephropathy should be considered in patients who develop acute renal failure following aggressive chemotherapy with appropriate tumor lysis syndrome prophylaxis. Urine measurements for xanthine could aid in the diagnosis of patients with nephrolithiasis complicating tumor lysis syndrome. Allopurinal dosage should be reduced or discontinued if xanthine nephropathy is suspected.

    View details for DOI 10.1007/s00467-006-0287-z

    View details for Web of Science ID 000242513200023

    View details for PubMedID 17039332

Stanford Medicine Resources:

Footer Links: